View Item 

Show simple item record

Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure
dc.contributor.authorDeedwania, Prakash C.en_US
dc.contributor.authorAhmed, Mustafa I.en_US
dc.contributor.authorFeller, Margaret A.en_US
dc.contributor.authorAban, Inmaculada B.en_US
dc.contributor.authorLove, Thomas E.en_US
dc.contributor.authorPitt, Bertramen_US
dc.contributor.authorAhmed, Alien_US
dc.date.accessioned2014-03-05T18:19:06Z
dc.date.available2014-03-05T18:19:06Z
dc.date.issued2011-05en_US
dc.identifier.citationDeedwania, Prakash C.; Ahmed, Mustafa I.; Feller, Margaret A.; Aban, Inmaculada B.; Love, Thomas E.; Pitt, Bertram; Ahmed, Ali (2011). "Impact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failure." European Journal of Heart Failure 13(5): 551-559. <http://hdl.handle.net/2027.42/106120>en_US
dc.identifier.issn1388-9842en_US
dc.identifier.issn1879-0844en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/106120
dc.publisherWiley Periodicals, Inc.en_US
dc.publisherSpringer‐Verlagen_US
dc.subject.otherRecurrent Myocardial Infarctionen_US
dc.subject.otherDiabetesen_US
dc.titleImpact of diabetes mellitus on outcomes in patients with acute myocardial infarction and systolic heart failureen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelCardiovascular Medicineen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.description.peerreviewedPeer Revieweden_US
dc.identifier.pmid21393298en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/106120/1/ejhfhfr009.pdf
dc.identifier.doi10.1093/eurjhf/hfr009en_US
dc.identifier.sourceEuropean Journal of Heart Failureen_US
dc.identifier.citedreferenceSpiro MJ Kumar BR Crowley TJ Myocardial glycoproteins in diabetes: type VI collagen is a major PAS‐reactive extracellular matrix protein J Mol Cell Cardiol 1992 24 397 410en_US
dc.identifier.citedreferencePitt B Remme W Zannad F Neaton J Martinez F Roniker B Bittman R Hurley S Kleiman J Gatlin M Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction N Engl J Med 2003 348 1309 1321en_US
dc.identifier.citedreferenceD'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non‐randomized control group Stat Med 1998 17 2265 2281en_US
dc.identifier.citedreferenceNormand ST Landrum MB Guadagnoli E Ayanian JZ Ryan TJ Cleary PD McNeil BJ Validating recommendations for coronary angiography following acute myocardial infarction in the elderly: a matched analysis using propensity scores J Clin Epidemiol 2001 54 387 398en_US
dc.identifier.citedreferenceRosenbaum PR Rosenbaum PR Sensitivity to hidden bias Observational Studies 2002 2nd edn New York Springer‐Verlag 110 124en_US
dc.identifier.citedreferenceO'Keefe JH Abuissa H Pitt B Eplerenone improves prognosis in postmyocardial infarction diabetic patients with heart failure: results from EPHESUS Diabetes Obes Metab 2008 10 492 497en_US
dc.identifier.citedreferenceWallander M Norhammar A Malmberg K Ohrvik J Ryden L Brismar K IGF binding protein 1 predicts cardiovascular morbidity and mortality in patients with acute myocardial infarction and type 2 diabetes Diabetes Care 2007 30 2343 2348en_US
dc.identifier.citedreferenceTenenbaum A Fisman EZ Boyko V Goldbourt U Auerbach I Shemesh J Shotan A Reicher‐Reiss H Behar S Motro M Prevalence and prognostic significance of unrecognized systemic hypertension in patients with diabetes mellitus and healed myocardial infarction and/or stable angina pectoris Am J Cardiol 1999 84 294 298en_US
dc.identifier.citedreferenceJimenez‐Navarro M Gomez‐Doblas JJ Hernandez Garcia JM Alonso‐Briales J Garcia Alcantara A Gomez G Rodriguez‐Bailon I de Teresa E Does angina pectoris the week before protect against first acute myocardial infarction in patients with diabetes mellitus? Am J Cardiol 2002 90 160 162en_US
dc.identifier.citedreferenceMalmberg K Norhammar A Wedel H Ryden L Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long‐term results from the Diabetes and Insulin‐Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study Circulation 1999 99 2626 2632en_US
dc.identifier.citedreferenceLim HS MacFadyen RJ Lip GY Diabetes mellitus, the renin‐angiotensin‐aldosterone system, and the heart Arch Intern Med 2004 164 1737 1748en_US
dc.identifier.citedreferenceMiller JA Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus J Am Soc Nephrol 1999 10 1778 1785en_US
dc.identifier.citedreferenceAronson D Cross‐linking of glycated collagen in the pathogenesis of arterial and myocardial stiffening of aging and diabetes J Hypertens 2003 21 3 12en_US
dc.identifier.citedreferenceBasta G Schmidt AM De Caterina R Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes Cardiovasc Res 2004 63 582 592en_US
dc.identifier.citedreferenceLopez Y Paloma MJ Rifon J Cuesta B Paramo JA Measurement of prethrombotic markers in the assessment of acquired hypercoagulable states Thromb Res 1999 93 71 78en_US
dc.identifier.citedreferenceCarr ME Diabetes mellitus: a hypercoagulable state J Diabetes Complications 2001 15 44 54en_US
dc.identifier.citedreferenceCollier A Rumley A Rumley AG Paterson JR Leach JP Lowe GD Small M Free radical activity and hemostatic factors in NIDDM patients with and without microalbuminuria Diabetes 1992 41 909 913en_US
dc.identifier.citedreferenceBarbash GI White HD Modan M Van de Werf F Significance of diabetes mellitus in patients with acute myocardial infarction receiving thrombolytic therapy. Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Trial J Am Coll Cardiol 1993 22 707 713en_US
dc.identifier.citedreferenceAbbud ZA Shindler DM Wilson AC Kostis JB Effect of diabetes mellitus on short‐ and long‐term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group Am Heart J 1995 130 51 58en_US
dc.identifier.citedreferenceVaccarino V Parsons L Every NR Barron HV Krumholz HM Impact of history of diabetes mellitus on hospital mortality in men and women with first acute myocardial infarction. The National Registry of Myocardial Infarction 2 Participants Am J Cardiol 2000 85 1486 1489 A1487en_US
dc.identifier.citedreferenceIshihara M Sato H Kawagoe T Shimatani Y Kurisu S Nishioka K Kouno Y Umemura T Nakamura S Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease Heart 2001 86 133 138en_US
dc.identifier.citedreferenceClarke R Shipley M Lewington S Youngman L Collins R Marmot M Peto R Underestimation of risk associations due to regression dilution in long‐term follow‐up of prospective studies Am J Epidemiol 1999 150 341 353en_US
dc.identifier.citedreferenceMelchior T Kober L Madsen CR Seibaek M Jensen GV Hildebrandt P Torp‐Pedersen C Accelerating impact of diabetes mellitus on mortality in the years following an acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation Eur Heart J 1999 20 973 978en_US
dc.identifier.citedreferenceZuanetti G Latini R Maggioni AP Santoro L Franzosi MG Influence of diabetes on mortality in acute myocardial infarction: data from the GISSI‐2 study J Am Coll Cardiol 1993 22 1788 1794en_US
dc.identifier.citedreferenceAguilar D Solomon SD Kober L Rouleau JL Skali H McMurray JJ Francis GS Henis M O'Connor CM Diaz R Belenkov YN Varshavsky S Leimberger JD Velazquez EJ Califf RM Pfeffer MA Newly diagnosed and previously known diabetes mellitus and 1‐year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial Circulation 2004 110 1572 1578en_US
dc.identifier.citedreferenceAbbott RD Donahue RP Kannel WB Wilson PW The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study JAMA 1988 260 3456 3460en_US
dc.identifier.citedreferenceHaffner SM Lehto S Ronnemaa T Pyorala K Laakso M Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction N Engl J Med 1998 339 229 234en_US
dc.identifier.citedreferenceFitzmaurice G Confounding: regression adjustment Nutrition 2006 22 581 583en_US
dc.identifier.citedreferenceAhmed A Aban IB Vaccarino V Lloyd‐Jones DM Goff DC Jr. Zhao J Love TE Ritchie C Ovalle F Gambassi G Dell'Italia LJ A propensity‐matched study of the effect of diabetes on the natural history of heart failure: variations by sex and age Heart 2007 93 1584 1590en_US
dc.identifier.citedreferenceAhmed A Husain A Love TE Gambassi G Dell'Italia LJ Francis GS Gheorghiade M Allman RM Meleth S Bourge RC Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods Eur Heart J 2006 27 1431 1439en_US
dc.identifier.citedreferenceAhmed A Rich MW Sanders PW Perry GJ Bakris GL Zile MR Love TE Aban IB Shlipak MG Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study Am J Cardiol 2007 99 393 398en_US
dc.identifier.citedreferenceAhmed A Zannad F Love TE Tallaj J Gheorghiade M Ekundayo OJ Pitt B A propensity‐matched study of the association of low serum potassium levels and mortality in chronic heart failure Eur Heart J 2007 28 1334 1343en_US
dc.identifier.citedreferenceAhmed MI White M Ekundayo OJ Love TE Aban I Liu B Aronow WS Ahmed A A history of atrial fibrillation and outcomes in chronic advanced systolic heart failure: a propensity‐matched study Eur Heart J 2009 30 2029 2037en_US
dc.identifier.citedreferenceRosenbaum PR Rubin DB The central role of propensity score in observational studies for causal effects Biometrika 1983 70 41 55en_US
dc.identifier.citedreferenceRubin DB Using propensity score to help design observational studies: application to the tobacco litigation Health Serv Outcomes Res Methodol 2001 2 169 188en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ejhfhfr009.pdf
Size:
371.8KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.